IDE expression, which has been shown to influence Aβ levels in vitro and in vivo [13], is also impaired in the brains of AD patients and in Tg2576 transgenic mice and correlates with the accumulation of Aβ during the progression of the disease [14]. This evidence concerns the gene IDE and Alzheimer disease.